 |
|
'Nature vs. nurture' study of deceased donor pairs in kidney transplantation
April 22, 2009Minneapolis/St. Paul, MN -- The implications of a new study could improve the outcomes, and potentially survival rates, for some of the thousands of individuals who undergo kidney transplants each year. The study concluded that donor-related risk factors, yet to be identified, make a measurable contribution to the ultimate success or failure of a kidney transplant.
The study, "'Nature versus Nurture' Study of Deceased Donor Pairs in Kidney Transplantation," was supported by the Robert Wood Johnson Foundation Physician Faculty Scholars program and is to be published in the April 22nd online edition, and the June print edition, of the Journal of the American Society of Nephrology. It examines outcomes over a three-year period in pairs of kidney recipients, each of whom received a kidney from the same deceased donor.
The study found that when two recipients get their respective kidneys from a single deceased donor, certain so-called "unmeasured risk factors" in the donor can significantly contribute to both recipients' risk for two kinds of problems. The first problem is "delayed graft function" (DGF), or sluggish kidney function requiring a period of dialysis; the second is kidney failure.
According to Ajay Israni, M.D., M.S., lead author of the study, more research is needed to better understand what these "unmeasured risk factors" are. He added that changes are needed in public-health policy laws, so that when a patient's kidney fails, his or her provider is permitted to share that information with the provider whose patient received the partner kidney.
"If providers were allowed to share this critical information with each other, we could potentially increase survival rates by intervening with the surviving patients," Dr. Israni said. Examples of possible intervention strategies, he said, include an increase in monitoring and surveillance of the surviving patient, catching a potential kidney rejection before it gets out of control, and/or tailoring immunosuppressive drugs to reduce the possibility of rejection.
Dr. Israni is an Assistant Professor of Medicine and an Adjunct Assistant Professor of Epidemiology and Community Health at the University of Minnesota. He conducted the research as a member of the Robert Wood Johnson Physician Faculty Scholars program.
An additional finding of the study is that slight variations in medical procedures used at different transplant facilities had a less significant impact on kidney failure outcomes than the unmeasured risk factors did. However, transplant center procedures did have an effect on the rates of DGF. This finding suggests that there are variations in early post-transplant management at transplant centers that may be contributing to delayed kidney function.
Additional Study Information:
The study examined the risks of DGF and transplant failure within 19,461 recipient pairs having the same deceased donor and transplanted between 1995 and 2003, using data from the United States Renal Data System. It examined the within-pair correlation of these outcomes among recipients of kidneys from the same deceased donor, and adjusted for transplant center effect by estimating separate odds ratios (OR) for recipient pairs transplanted at the same transplant center and at different transplant centers. The authors detected the transplant-center effect by measuring the difference in outcomes for the paired kidneys from the same deceased donor transplanted at the same versus different centers.
Robert Wood Johnson Foundation Health & Society Scholars
According to Ajay Israni, M.D., M.S., lead author of the study, more research is needed to better understand what these "unmeasured risk factors" are. He added that changes are needed in public-health policy laws, so that when a patient's kidney fails, his or her provider is permitted to share that information with the provider whose patient received the partner kidney.
"If providers were allowed to share this critical information with each other, we could potentially increase survival rates by intervening with the surviving patients," Dr. Israni said. Examples of possible intervention strategies, he said, include an increase in monitoring and surveillance of the surviving patient, catching a potential kidney rejection before it gets out of control, and/or tailoring immunosuppressive drugs to reduce the possibility of rejection.
Dr. Israni is an Assistant Professor of Medicine and an Adjunct Assistant Professor of Epidemiology and Community Health at the University of Minnesota. He conducted the research as a member of the Robert Wood Johnson Physician Faculty Scholars program.
An additional finding of the study is that slight variations in medical procedures used at different transplant facilities had a less significant impact on kidney failure outcomes than the unmeasured risk factors did. However, transplant center procedures did have an effect on the rates of DGF. This finding suggests that there are variations in early post-transplant management at transplant centers that may be contributing to delayed kidney function.
Additional Study Information:
The study examined the risks of DGF and transplant failure within 19,461 recipient pairs having the same deceased donor and transplanted between 1995 and 2003, using data from the United States Renal Data System. It examined the within-pair correlation of these outcomes among recipients of kidneys from the same deceased donor, and adjusted for transplant center effect by estimating separate odds ratios (OR) for recipient pairs transplanted at the same transplant center and at different transplant centers. The authors detected the transplant-center effect by measuring the difference in outcomes for the paired kidneys from the same deceased donor transplanted at the same versus different centers.
Robert Wood Johnson Foundation Health & Society Scholars
Kidney Transplantation Current Events and Kidney Transplantation News RSSSwitching immunosuppressants reduces cancer risk in kidney
Switching to a newer type of immunosuppressant drug may reduce the high rate of skin cancer after kidney transplantation, according to research being presented at the American Society of Nephrology's 42nd Annual Meeting and Scientific Exposition in San Diego, CA.
Older kidney transplant patients should more often consider live donors
Almost half of kidney transplant candidates older than 60 who are put on the waiting list for a deceased-donor organ will die before getting a transplant.
Kidney transplant survival can be long-term for people with HIV
A Johns Hopkins study finds that HIV-positive kidney transplant recipients could have the same one-year survival rates for themselves and their donor organs as those without HIV, provided certain risk factors for transplant failure are recognized and tightly managed.
African-American Canadians who receive kidney transplants fare better than those in US
African American kidney disease patients in both Canada and the United States are less likely than Caucasian Americans to have access to kidney transplants, but only African-Americans in the United States have worse health outcomes than Caucasians after a transplant is performed.
Study Shows Steroid Therapies Following Transplant Can Be Eliminated
A new study by researchers at UC shows that using modern immunosuppressive drugs eliminates the need for steroid therapy as early as seven days following a transplant surgery while still maintaining kidney function
Annual Report Targets Chronic Kidney Disease in the United States
A 30 percent increase in chronic kidney disease over the past decade has prompted the U.S. Renal Data System (USRDS) to issue for the first time a separate report documenting the magnitude of the disease, which affects an estimated 27 million Americans and accounts for more than 24 percent of Medicare costs.
New protocol streamlines therapy that makes more kidney transplants possible
A new therapy developed at Cedars-Sinai Medical Center improves transplant rates and outcomes for patients awaiting living- and deceased-donor kidney transplantation, according to a study published in the July 17 issue of the New England Journal of Medicine.
Anti-rejection drug may increase risk of diabetes after kidney transplant
For patients undergoing kidney transplantation, treatment with the anti-rejection drug sirolimus may lead to an increased risk of diabetes, reports a study in the July Journal of the American Society of Nephrology (JASN).
Race, insurance status affect access to transplantation and kidney disease treatment
Universal access to health care might help to overcome racial and ethnic barriers to treatment for kidney disease, suggest two studies in the March 2008 issue of Clinical Journal of the American Society of Nephrology.
Kidney donor age linked to aortic siffening
Transplantation of kidneys from older donors is followed by increased stiffening of the recipient's aorta-which may help to explain the higher rates of cardiovascular disease and death in patients receiving kidneys from "expanded criteria" donors, reports a study in the April Journal of the American Society of Nephrology.
More Kidney Transplantation Current Events and Kidney Transplantation News Articles
 |
Kidney Transplantation: Principles and Practice (Morris,Kidney Transplantation) by Peter Morris AC FRS FRCS (Author), Stuart J. Knechtle MD (Author) Updated to reflect today's practice guidelines, the new edition of this comprehensive text remains the definitive resource on all aspects of renal transplantation, including immunological, pathological, psychological and ethical considerations. It examines evaluation, management, and procurement of living and deceased donor kidneys, the selection of suitable recipients, interpretation of graft dysfunction, and expected survival based upon a large database of information. There are comprehensive chapters on pediatric renal transplantation and on renal transplantation in the developing world. Extensive tables and figures and comprehensive lists of references with each chapter enhance its value to the transplant team. A multidisciplinary approach from internationally renowned contributors... |
 |
Handbook of Kidney Transplantation (Lippincott Williams & Wilkins Handbook) by Gabriel M Danovitch (Editor) This popular handbook is a practical guide for physicians, surgeons, nurses, and other professionals who manage kidney transplant patients. It is concise, readable, and well-illustrated. Chapters outline the major concerns surrounding renal transplantation and the most successful approaches to problems arising in short-term and long-term patient care. Chapter topics include immunobiology and immunosuppression, as well as chapters on surgery, histocompatibility, and the first three months post-transplant surgery. This thoroughly updated Fifth Edition includes new information on options for patients with end-stage renal disease, immunosuppressive medications and protocols for kidney transplantation, and the first two months following transplant. |
 |
Medical Complications of Kidney Transplantation by Claudio Ponticelli (Editor) With color illustrations throughout, this book analyzes the implications that transplantation and immunosuppression can hold for patients. Discussing the many complications that may occur after kidney transplantation, this source is a must for anyone caring for patients recovering from this type of procedure. |
|
Saudi Journal of Kidney Diseases and Transplantation by Saudi Ctr Organ Transplantatio Publication is a nephrology and organ transplantation journal. | |
 |
Handbook Of Kidney Transplantation -9780781793742 by Lippincott Williams & Wilkins Handbook of Kidney Transplantation -9780781793742 : Handbook of Kidney Transplantation Pub Date: October 2009 Product Type: Print Author/s: Gabriel M Danovitch MD This popular handbook is a practical guide for physicians, surgeons, nurses, and other professionals who manage kidney transplant patients. It is concise, readable, and well-illustrated. Chapters outline the major concerns surrounding renal transplantation and the most successful approaches to problems arising in short-term and long-term patient care.Chapter topics include immunobiology and immunosuppression, as well as chapters on surgery, histocompatibility, and the first three months post-transplant surgery. This thoroughly updated Fifth Edition includes new information on options for patients with... |
 |
Manual of Kidney Transplant Medical Care (Transplant Care Series) by Arthur J. Matas (Author) Written for health care practitioners who care for pre- or post-operative kidney transplant recipients but who are not necessarily experts in transplant medicine. Explains common medical problems experienced by transplant recipients, factors to consider when prescribing medications, etc. |
 |
The Most Precious Gift by Lawrence Liebling (Author) What would you do if someone close to you was about to die unless you put your own life on the line? There is a moment in ever person's life that has the power to be so defining that it changes the lens through which he or she sees the world. For author Lawrence Liebling, that moment occurs in 1974 when his sister, gravely ill for four years, is desperately in need of a new and risky medical procedure, a kidney transplant. At the age of 20, he is asked to be the donor and he consents. The operation is a success, but the immediate results hide unforeseen consequences. This true story follows relationships over the span of the next 25 years, as they twist and turn down a path of joy and celebration, as well as hardship and tragedy. The Most Precious Gift is more than a... |
 |
Kidney Transplantation: Strategies To Prevent Organ Rejection (Contributions to Nephrology) by C. Ronco (Editor), Stefano Chiaramonte (Editor), Giuseppe Remuzzi (Editor) Transplantation is today firmly established as the therapy of choice for end-stage organ failure. However, despite recent developments, this therapy is still not without challenges and risks: The necessity to take immunosuppressive drugs for the rest of one's life to prevent allograft rejection trades the morbidity and mortality of organ failure for the risks of infection and cancer as well as for an increased mortality from cardiovascular disease. Thus, there is an urgent need for optimizing the outcome of transplantation by achieving long-term, drug-free graft acceptance with normal organ function. Recently, numerous insights into the dynamic inter-relationship of host immune responses elicited by donor antigen presentation have substantially broadened our understanding of the cascade... |
 |
Handbook Of Kidney Transplantation -9780781753227 by Lippincott Williams & Wilkins Handbook of Kidney Transplantation -9780781753227 : Handbook of Kidney Transplantation Pub Date: August 2004 Product Type: Print Author/s: Gabriel M Danovitch MD Now in its updated Fourth Edition, this popular handbook is a practical guide for physicians and surgeons who manage kidney transplant patients and for nurses and other professionals on the transplant team. In concise, readable, well-illustrated chapters, the book outlines the major concerns surrounding renal transplantation and the most successful approaches to problems arising in short-term and long-term patient care. This edition's chapters on immunobiology and immunosuppression have been completely rewritten to reflect recent advances. Chapters on surgery, histocompatibility, and the first three months... |
 |
Kidney and Pancreas Transplantation: Detailed Surgical Procedures and Management Protocols (Landes Bioscience Medical Handbook (Vademecum)) by Ingemar J.A. Davidson (Author) List Price - $45.00 |
| © 2009 BrightSurf.com |